Platelet sequestration with a new‐generation autotransfusion device

BACKGROUND Autologous platelet‐rich plasma (PRP) can be used either to prevent platelets (PLTs) from lesions during extracorporeal circulation or for wound therapy, when processed into PLT gel. The aim of this study was to evaluate the PLT sequestration abilities of a new‐generation autotransfusion device. STUDY DESIGN AND METHODS In this experimental study the discontinuous, new‐generation autotransfusion device XTRA was evaluated using fresh donor blood. The blood was processed in four different size bowls (X55, X125, X175, X225 [bowls' size in mL]) using the device's built‐in “PLT sequestration program.” PLT functionality was tested using aggregometry; for PLT activation, β‐thromboglobulin (β‐TG) and soluble P‐selectin levels were determined. Cell damage was assessed by a morphology score and hypotonic shock response. Additionally, PLTs were tested after 6 hours to identify storage lesions. RESULTS Platelet recovery in the PRP ranged from 39% to 64% and averaged 6.2‐fold PLT enrichment as defined by the increase in PLT concentration. The preparation caused minimal cell damage and a decrease in cell function by only 10%, but a slight activation was observed amounting to 9% of the maximal β‐TG release. The efficiency of the preparation, represented by the PLT recovery rate, increased in a linear fashion with the increasing bowl sizes being tested. After 6 hours of storage the prepared PLTs showed an additional 9% loss in function, but only 4% decrease in viability. CONCLUSION The autotransfusion device XTRA was capable of high‐quality perioperative PRP preparation, and the bowl size was found to have an influence on the efficiency of the preparation.